top of page
FORGE NEWS


Business Development Manager (Remote, UK/Europe)
Business Development Manager Job title: Business Development Manager Location: Remote (UK or Europe-based) Salary: £45,000–£90,000 base salary Contract: Full time Travel: Extensive international travel required Eligibility: Applicants must already have the right to work in the UK or an EU/EEA country About Forge Genetics Forge Genetics is a growing biotechnology company developing microbial genome engineering technologies and providing R&D services to academic and commercial
Craig Woods
Jan 213 min read


Forge Genetics announces collaboration with Unilever
Bacterial species and strains vary wildly in our ability to manipulate them. Model species such as Escherichia coli and Bacillus subtilis are readily transformable and have a range of genetic tools but more exotic, non-model species can present a whole manner of challenges. This is unfortunate because a multitude of interesting, impactful or useful traits are found within non-model species and full exploitation of these traits requires genetic studies. Non-model species are
Craig Woods
Oct 1, 20252 min read


New Chair of the Board: Paul Edwards MBE
Paul brings over 40 years of experience in life sciences, including senior leadership roles at Beecham Pharmaceuticals, Genzyme, and GeneMedix where he led the company’s dual listing on the London and Singapore Stock Exchanges. Forge has grown rapidly since its founding two years ago. We’ve developed and deployed a powerful, novel genetic engineering platform to solve problems for leading pharmaceutical and biotech companies. With Paul’s experience in scaling biotech business
Craig Woods
Sep 22, 20251 min read


£2m investment to accelerate Forge Editing and company growth
Forge Genetics has raised £2m in equity funding from the Midlands Engine Investment Fund II, through its appointed fund manager Mercia Ventures, with support from the British Business Bank. The investment will allow us to scale our commercial work developing engineered bacterial strains for pharmaceutical and biotechnology companies, while accelerating R&D to adapt Forge Editing for use in mammalian cells. Since launching less than two years ago, we have secured over £2m in c
Craig Woods
Aug 30, 20251 min read
bottom of page
